The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -64.12%.However, over the last six months, we can see a stronger performance of -64.29%. Over the last 30 days, the price of VIVS has leaped by -30.28%. And in the last five days, it has surged by 19.28%.
VivoSim Labs Inc experienced a rather shaky stock market performance.
52-week price history of VIVS Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. VivoSim Labs Inc’s current trading price is -90.98% away from its 52-week high, while its distance from the 52-week low is 26.92%. The stock’s price range during this period has varied between$1.56 and $21.96. The VivoSim Labs Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.85 million for the day, a figure considerably higher than their average daily volume of 0.75 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
VivoSim Labs Inc (VIVS) has experienced a quarterly decline of -53.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.37M and boasts a workforce of 20 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
VIVS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VIVS stands at 3.67. Similarly, the long-term debt-to-equity ratio is also 1.50.
